ARCHIVES

NCI To Use Technology Transfer Agreement To Privatize Journal In A Five-Year Deal

This article is from The Cancer Letter archive.

Vol. 21 No. 46 | December 1, 1995

Download PDF Visit The Full Archive

Related Articles

Anil Potti Reprimanded by North Carolina Licensure Board

December 9, 2011

FDA Advisors Unanimously Turn Down GPC Biotech’s Orplatna for Prostate Cancer.

July 27, 2007

Mandates Not welcome In Steady State Funding, Varmus Tells Senate

March 15, 1996

Van Brings Free Brain MRIs To Capitol Hill; Experts See Enormous Potential For Harm

May 8, 2009

Biostatistician Thomas Fleming Warns Against Approval of Provenge.

May 4, 2007

Preserve NCI’s Role In Applied Research And Its Unique Environment, Chabner Says

May 12, 1995